WO2022138081A1 - Inhalateur pour traitement - Google Patents

Inhalateur pour traitement Download PDF

Info

Publication number
WO2022138081A1
WO2022138081A1 PCT/JP2021/044545 JP2021044545W WO2022138081A1 WO 2022138081 A1 WO2022138081 A1 WO 2022138081A1 JP 2021044545 W JP2021044545 W JP 2021044545W WO 2022138081 A1 WO2022138081 A1 WO 2022138081A1
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
history information
nebulizer
response
unit
Prior art date
Application number
PCT/JP2021/044545
Other languages
English (en)
Japanese (ja)
Inventor
麻 平澤
賢吾 西山
友香 田邊
真郎 前田
美由紀 足達
Original Assignee
オムロンヘルスケア株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オムロンヘルスケア株式会社 filed Critical オムロンヘルスケア株式会社
Publication of WO2022138081A1 publication Critical patent/WO2022138081A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes

Definitions

  • the present invention relates to a therapeutic inhaler.
  • Patent Document 2 describes an asthma treatment support system suitable for transmitting, managing and displaying the usage status of an aerosol type (pressurized fixed-quantity spray type) portable inhaler.
  • the transmitter attached to the inhaler detects the operation of the can containing the drug by the user's finger, it calculates the number of times the inhaler has been used based on the detected result and sends it to the management server. ing.
  • Treatment using a therapeutic inhaler such as a nebulizer configured to be able to inhale the atomized drug solution is required to be performed at the frequency specified by the doctor.
  • a therapeutic inhaler such as a nebulizer configured to be able to inhale the atomized drug solution
  • one treatment using a therapeutic inhaler means that an operation of inhaling the same type of drug for a predetermined time (for example, 5 minutes or the like) is performed. For example, if the operation history of the therapeutic inhaler can be confirmed later by the doctor, it becomes possible to judge whether or not the treatment is performed at an appropriate frequency, which can be useful for deciding the treatment policy.
  • Such therapeutic inhalers are often used for children such as babies or toddlers. However, it is difficult for children to stay still for long periods of time. Therefore, even when one treatment is performed, it is assumed that the inhalation and inhalation are interrupted after the spraying and inhalation of the drug solution are started, and the spraying and inhalation are restarted after a while. In order to determine whether treatment has been performed at an appropriate frequency, it is preferable to be able to separately manage the temporary stop of spraying due to such interruption and the stoppage of spraying due to the end of treatment.
  • An object of the present invention is to provide a therapeutic inhaler capable of appropriately managing the history of treatment.
  • It is a therapeutic inhaler configured to be able to inhale the drug solution atomized by the atomizing part. Performing a treatment start operation instructing the start of treatment, a treatment end operation instructing the end of treatment, a treatment discontinuation operation instructing discontinuation of treatment, and a treatment resumption operation instructing resumption of interrupted treatment.
  • It is equipped with a processor that manages the transmission of the operation history information of the atomization unit to an external device.
  • the processor is a therapeutic inhaler that changes the content of the management according to the operation content of the operating member.
  • the operation history information after the resumption of treatment is prevented from being transmitted to the external device, the operation history information before the discontinuation of the treatment and the operation after the resumption of the treatment are performed. It is possible to identify that the historical information is information indicating that the atomized portion has been activated for the same treatment. Therefore, even when the operation history information transmitted to the external device is referred to, it is possible to prevent one treatment from being recognized as a plurality of treatments. Therefore, the frequency of treatment using the therapeutic inhaler can be accurately grasped, which can be useful for determining the treatment policy.
  • common identification information is associated with the operation history information from the start of the treatment to the interruption of the treatment and the operation history information from the resumption of the treatment to the end of the treatment. Therefore, by referring to this identification information, it becomes possible to recognize that the operation of the atomizing portion is performed a plurality of times for one treatment. As a result, the frequency of treatment using the therapeutic inhaler can be accurately grasped.
  • the operation history information is a therapeutic inhaler including the operation time of the atomizing portion.
  • the inhalation amount of the drug solution in one treatment can be roughly grasped by the total value of the operation time included in each of the plurality of operation history information to which the common identification information is associated. Therefore, the doctor can determine whether the appropriate treatment is performed by the user, which can be useful for determining the treatment policy.
  • the therapeutic inhaler according to the above.
  • the processor activates the atomization unit in response to the treatment start operation, the processor transmits operation history information regarding the operation of the atomization unit started in response to the treatment start operation to the external device.
  • the atomization unit is operated in response to the treatment resumption operation, transmission of operation history information regarding the operation of the atomization unit started in response to the treatment resumption operation to the external device is omitted.
  • Therapeutic inhaler When the processor activates the atomization unit in response to the treatment start operation, the processor transmits operation history information regarding the operation of the atomization unit started in response to the treatment start operation to the external device.
  • the history of treatment can be appropriately managed.
  • FIG. 2 It is a schematic diagram which shows the schematic structure of the treatment management system. It is an exploded perspective view of the nebulizer shown in FIG. It is a vertical sectional view of the nebulizer shown in FIG. 2 as seen from the right side (direction indicated by arrow A in FIG. 2). It is a schematic diagram explaining the use state of the nebulizer shown in FIG. It is a figure which shows the block structure of the nebulizer shown in FIG. It is a timing chart for demonstrating the operation of the nebulizer control part when the treatment is completed by one operation of the atomization part. It is a timing chart for demonstrating the operation of the nebulizer control part when the treatment is completed by the operation of the atomization part twice. It is a timing chart for demonstrating the variation example of the operation of the nebulizer control part when the treatment is completed by the operation of the atomization part twice.
  • the nebulizer has a treatment start operation for instructing the start of treatment (operation of the atomization portion), a treatment end operation for instructing the end of treatment (stop of the atomization portion), and interruption of treatment. It is possible to perform a treatment interruption operation instructing (pause of the operation of the atomization part) and a treatment resumption operation instructing the resumption of the interrupted treatment (release of the suspension of the operation of the atomization part). It has an operating member.
  • the nebulizer is further configured to be communicable with an external device, and has a function of managing the transmission of the operation history information of the atomizing unit to the external device when the atomizing unit is activated. The nebulizer changes the content of this management according to the operation content of the operating member.
  • the nebulizer when the nebulizer activates the atomized portion in response to the treatment start operation, the nebulizer transmits the operation history information regarding the operation of the atomized portion started in response to the treatment start operation to an external device and restarts the treatment.
  • the atomization unit When the atomization unit is operated in response to the operation, the transmission of the operation history information regarding the operation of the atomization unit started in response to the treatment restart operation to the external device is omitted.
  • the treatment is interrupted, only the operation history information regarding the operation of the atomizing portion from the start of the treatment to the interruption of the treatment is transmitted to the external device.
  • FIG. 1 is a schematic diagram showing a schematic configuration of the treatment management system 100.
  • the treatment management system 100 includes a nebulizer 1 as a therapeutic inhaler for treating a respiratory disease by inhaling a sprayed drug solution, and an electron possessed by a user of the nebulizer 1 or a related person (for example, a parent of the user). It includes a device 3 and a management server 6.
  • the electronic device 3 is an electronic device having a communication function such as a personal computer, a smartphone, or a tablet terminal.
  • the electronic device 3 is configured to be able to communicate with the management server 6 via a network 4 such as the Internet.
  • the electronic device 3 is configured to be communicable with the nebulizer 1 based on a short-range communication standard such as Bluetooth (registered trademark) or Wi-Fi.
  • the treatment management application provided by the operator of the treatment management system 100 is installed in the electronic device 3.
  • This treatment management application information transmission / reception between the nebulizer 1 and the electronic device 3, information transmission from the electronic device 3 to the management server 6, and an electronic device for display data generated by the management server 6 are performed. It is possible to browse by 3.
  • the management server 6 includes a communication interface (IF) 61 for communicating with a device connected to the network 4, a server control unit 62, and a database 63.
  • the database 63 may be a storage externally attached to the management server 6 or a network storage connected to the network 4.
  • the server control unit 62 controls the entire management server 6 in an integrated manner, and stores a processor such as a CPU (Central Processing Unit) that executes a program and performs processing, and a ROM (Read) that stores the program or the like executed by this processor. Only Memory) and RAM (Random Access Memory) as a work memory are included.
  • a processor such as a CPU (Central Processing Unit) that executes a program and performs processing
  • ROM Read
  • Only Memory and RAM Random Access Memory
  • the structure of the processor described in the present specification is an electric circuit in which circuit elements such as semiconductor elements are combined.
  • the server control unit 62 acquires the information transmitted from the nebulizer 1 to the electronic device 3 and transferred from the electronic device 3 via the communication interface 61, and records the acquired information in the database 63. By processing the information recorded in the database 63, the server control unit 62 processes the treatment results such as the timing (treatment timing) of the treatment performed using the nebulizer 1 and the time (treatment time) of the treatment. Generate display data to display.
  • the server control unit 62 requests viewing of this display data from the electronic device 3 or another electronic device connected to the network 4 (for example, a device operated by a doctor in charge of examining the user of the nebulizer 1). Upon receiving the image, the image based on the display data is controlled to be displayed on the requesting electronic device.
  • FIG. 2 is an exploded perspective view of the nebulizer 1 shown in FIG.
  • FIG. 3 is a vertical cross-sectional view of the nebulizer 1 shown in FIG. 2 as viewed from the right side (direction indicated by an arrow A in FIG. 2).
  • the nebulizer 1 includes a main body lower portion 11 having a substantially elliptical columnar outer shape, and a main body upper portion 12 mounted detachably fitted to the main body lower portion 11 from above. It includes a main body 10, a mounting member 20 mounted on the main body upper portion 12, and a cap member 30 configured to be openable and closable with respect to the main body upper portion 12.
  • the front half portion 12F of the main body upper portion 12 has a substantially columnar outer shape
  • the latter half portion 12R of the main body upper portion 12 has a substantially trapezoidal columnar outer shape.
  • an operation member 50 including a start / end button 51, a drug solution selection button 52, and a suspend / resume button 53, and a drug solution type selected by the drug solution selection button 52 are displayed.
  • Light emitting units 81, 82, and 83 for notifying are provided.
  • a recess 16 having a substantially circular planar shape opened upward so as to receive the mounting member 20 is provided on the upper surface of the front half portion 12F of the upper part 12 of the main body.
  • the recess 16 has a bottom surface 16b that is inclined with respect to the vertical direction (vertical direction) of the main body 10, and a side surface 16c that is continuous with the bottom surface 16b and gradually opens upward.
  • the ridges 19f and 19r are provided in a specific direction (front side, rear side in this example) at the edge portion 15 around the recess 16.
  • the ridge 19f on the front side has a planar shape protruding in an arc shape toward the center of the recess 16.
  • the ridge 19r on the rear side has a planar shape recessed in an arc shape when viewed from the center of the recess 16.
  • the ridges 19f and 19r are planned to be fitted to the flange portion 24 of the mounting member 20.
  • a packing 29 made of an annular elastic body is provided on the side surface 16c of the recess 16 so as to surround and contact the side wall portion 23 of the mounting member 20 in the circumferential direction.
  • a vibrating portion 40 is provided at a position corresponding to the recess 16 inside the front half portion 12F of the main body upper portion 12.
  • the vibrating portion 40 includes an ultrasonic vibrator 41 arranged at a position downwardly separated from the recess 16, a vibrating surface 43 horizontally arranged at a position corresponding to the bottom surface 16b of the recess 16, and an ultrasonic vibrator 41. It includes a horn 42 that is arranged between the vibration surface 43 and amplifies the vibration of the ultrasonic vibrator 41 and transmits the vibration to the vibration surface 43.
  • the drive voltage for the ultrasonic vibrator 41 is supplied from the lower part 11 of the main body via the contact electrode provided between the upper part 12 of the main body and the lower part 11 of the main body.
  • a liquid storage portion 17 having a substantially semicircular planar shape is provided in the latter half portion 12R of the upper portion 12 of the main body.
  • the liquid storage unit 17 has a bottom surface 17b that gradually becomes shallower toward the front side.
  • a liquid supply passage 18 for supplying a liquid (chemical solution) from the liquid storage unit 17 toward the vibrating surface 43 of the vibrating unit 40 is provided so as to be connected to the front surface side portion of the liquid storage unit 17.
  • the liquid storage unit 17 is open upward. Therefore, the user can put a liquid such as a chemical solution into the liquid storage unit 17 from above.
  • a cap member 30 forming a lid is connected to the upper edge of the latter half portion 12R of the main body upper portion 12 so as to be rotatable with respect to the main body upper portion 12 via a hinge 38.
  • the cap member 30 includes a latter half portion 30R arranged on the side close to the hinge 38 and having a substantially trapezoidal planar shape, and a front half portion 30F which is connected to the latter half portion 30R and has a substantially circular planar shape.
  • the portion 33 is provided so as to project.
  • a mesa portion 34 having a substantially trapezoidal planar shape corresponding to the planar shape of the liquid storage portion 17 is provided on the side of the latter half portion 30R of the cap member 30 facing the upper surface of the upper portion 12 of the main body.
  • the protrusion 33 works to position the mounting member 20.
  • the mesa section 34 closes the upper portion of the liquid storage section 17 to prevent the chemical solution from overflowing from the liquid storage section 17.
  • the center of the front half portion 30F of the cap member 30 is an opening 30o to which a mouthpiece or the like should be attached.
  • the leading edge 30Fe (opposite to the hinge 38) of the front half portion 30F of the cap member 30 is provided with an engaging protrusion 31 protruding inward.
  • the front half portion 12F of the upper portion 12 of the main body is provided with an engaging protrusion 14 projecting outward (forward) from the front end.
  • the mounting member 20 is mounted in the recess 16 of the upper part 12 of the main body when the nebulizer 1 is used.
  • the mounting member 20 should be connected to the flat film-like sheet 21 that should face the vibration surface 43, the bottom plate portion 22 that supports the sheet 21, and the outer edge of the bottom plate portion 22, and should face the side surface 16c of the recess 16.
  • the sheet 21 is attached to the lower surface of the bottom plate portion 22 by adhesion or welding.
  • the substantially central region of the sheet 21 constitutes the mesh portion 21a.
  • a user who intends to use the nebulizer 1 has a recess 16 having a shape that opens upward of the main body 10 with the cap member 30 open to the main body 10, as shown by an arrow D in FIG.
  • the mounting member 20 having the mesh portion 21a is mounted. With the mounting member 20 mounted, the user rotates and closes the cap member 30 with respect to the main body 10 (main body upper portion 12) via the hinge 38. Then, the engaging protrusion 31 of the cap member 30 engages with the engaging protrusion 14 of the upper part 12 of the main body in the vertical direction. As a result, the cap member 30 is fixed to the upper portion 12 of the main body in a closed state. In this way, the nebulizer 1 is easily assembled. This state is called the assembled state.
  • nebulizer When using the nebulizer 1, the user previously puts a chemical solution in the liquid storage unit 17 of the upper part 12 of the main body. Then, as shown in FIG. 4, the user attaches, for example, the mouthpiece 80 to the opening 30o of the cap member 30 in the assembled state. Instead of the mouthpiece 80, an inhalation mask that covers the face of the user 99 may be worn.
  • the chemical solution is supplied from the liquid storage section 17 through the liquid supply path 18 toward the vibrating surface 43 of the vibrating section 40. That is, the chemical solution is supplied between the vibrating surface 43 and the mesh portion 21a.
  • the chemical solution is passed through the mesh portion 21a (more accurately, a plurality of through holes penetrating the sheet 21). 90 is atomized and spouts.
  • the vibrating portion 40 and the mesh portion 21a of the mounting member 20 constitute an atomizing unit (the atomizing unit 73 described later) for atomizing a liquid such as a chemical solution stored in the liquid storage unit 17.
  • FIG. 5 is a diagram showing a block configuration of the nebulizer 1.
  • the nebulizer 1 includes an operation member 50, a nebulizer control unit 71, an oscillation frequency generation unit 72, an atomization unit 73, a communication interface 74, and a notification unit 75.
  • the start / end button 51 included in the operation member 50 is a treatment start operation for instructing the nebulizer control unit 71 to start treatment (in other words, start of operation of the atomization unit 73) and an end of treatment (in other words, fog). It is an operation member capable of performing a treatment end operation instructing the nebulizer control unit 71 (stopping the operation of the chemical unit 73). For example, a short press operation of the start / end button 51 in a state where the atomizing unit 73 is not operating is a treatment start operation, and a short press operation of the start / end button 51 after the treatment start operation is a treatment end operation. ..
  • the start / end button 51 may be divided into two, a button for performing the treatment start operation and a button for performing the treatment end operation.
  • the interrupt / resume button 53 included in the operation member 50 is a treatment interruption operation for instructing an interruption of treatment (in other words, a pause in the operation of the atomizing unit 73) and a resumption of the interrupted treatment (in other words, atomization). It is an operation member capable of performing a treatment restart operation for instructing (release of suspension of operation of the unit 73).
  • the suspend / resume button 53 is effective when the treatment start operation is performed by the start / end button 51.
  • a short press operation of the suspend / resume button 53 is a treatment interrupt operation
  • a short press operation of the suspend / resume button 53 after the treatment interrupt operation is a treatment restart operation.
  • the suspend / resume button 53 may be divided into two, a button for performing the treatment interruption operation and a button for performing the treatment restart operation.
  • the start / end button 51 may also be used as the suspend / resume button 53.
  • a long press operation of the start / end button 51 is a treatment start operation
  • a long press operation of the start / end button 51 after the treatment start operation is a treatment end operation
  • a start / end operation after the treatment start operation is regarded as the treatment interruption operation
  • the short-pressing operation of the start / end button 51 after the treatment interruption operation is referred to as the treatment restart operation.
  • the chemical solution selection button 52 included in the operation member 50 is an operation member for the user to select the type of the chemical solution used for the treatment using the nebulizer 1.
  • the notification unit 75 includes light emitting units 81, 82, and 83 shown in FIG. 2.
  • Each of the light emitting units 81, 82, and 83 includes a light emitting element such as an LED (light emitting diode).
  • information of different drug solution types can be registered in association with the light emitting units 81, 82, and 83.
  • the chemical solution selection button 52 By operating the chemical solution selection button 52, the user can sequentially switch between a state in which the light emitting unit 81 is lit, a state in which the light emitting unit 82 is lit, and a state in which the light emitting unit 83 is lit. Then, the type of the chemical solution corresponding to the lit light emitting unit is recognized by the nebulizer control unit 71 as the chemical solution selected by the user.
  • the oscillation frequency generation unit 72 applies an AC drive voltage to the ultrasonic vibrator 41 of the vibration unit 40 based on the control signal from the nebulizer control unit 71.
  • the state in which the driving voltage is applied to the ultrasonic vibrator 41 is referred to as the state in which the atomizing unit 73 is operating, and the state in which the driving voltage is not applied to the ultrasonic vibrator 41 is referred to as a state in which the atomizing unit 73 is operating. It is said that the atomization unit 73 is stopped.
  • the nebulizer control unit 71 is configured to include a processor such as a CPU, and performs various processes on this processor.
  • the nebulizer control unit 71 detects either the treatment start operation or the treatment restart operation while the atomization unit 73 is not operating, the nebulizer control unit 71 operates the atomization unit 73, and the atomization unit 73 is in the operating state.
  • the atomizing unit 73 is stopped.
  • the nebulizer control unit 71 manages the transmission of the operation history information of the atomizing unit 73 regarding the operation to the electronic device 3.
  • a specific description will be given.
  • the nebulizer control unit 71 operates the atomization unit 73 at each of the timing when the treatment start operation is detected (specifically, the date and time) and the timing when the treatment restart operation is detected (specifically, the date and time). Treat as start timing. Further, the nebulizer control unit 71 sets each of the timing when the treatment interruption operation is detected (specifically, the date and time) and the timing when the treatment end operation is detected (specifically, the date and time) as the operation end timing of the atomization unit 73. handle. Further, the nebulizer control unit 71 handles the time from the operation start timing to the operation end timing immediately after that as the operation time of the atomization unit 73. These operation start timings, operation end timings, and operation times each constitute operation history information of the atomizing unit 73.
  • FIG. 6 is a timing chart for explaining the operation of the nebulizer control unit 71 when the treatment is completed by one operation of the atomization unit 73.
  • the nebulizer control unit 71 activates the atomization unit 73 when the treatment start operation is detected at the timing t1, and stops the operation of the atomization unit 73 when the treatment end operation is detected at the timing t2. Further, when the nebulizer control unit 71 detects the treatment end operation at the timing t2, the nebulizer control unit 71 generates the operation history information J1 regarding the operation of the atomization unit 73 started at the timing t1.
  • the operation history information J1 has three: timing t1 (operation start timing), time between timing t1 and timing t2 (operation time of atomizing unit 73), and chemical type atomized by atomizing unit 73. Consists of seeds.
  • the nebulizer control unit 71 has, in the operation history information J1, identification information indicating that the operation is for one treatment (information unique to each time the treatment start operation is performed, and here, "M1". ) Is added. Then, the nebulizer control unit 71 transmits the operation history information J1 to which the identification information “M1” is added to the electronic device 3 at the timing t3 after the atomization unit 73 is stopped.
  • the electronic device 3 that has received the operation history information J1 from the nebulizer 1 transfers the operation history information J1 to the management server 6.
  • this operation history information J1 is recorded in the database 63.
  • FIG. 7 is a timing chart for explaining the operation of the nebulizer control unit 71 when the treatment is completed by the operation of the atomization unit 73 twice.
  • the nebulizer control unit 71 When the nebulizer control unit 71 detects the treatment start operation at the timing t4, the nebulizer control unit 71 activates the atomization unit 73. When the nebulizer control unit 71 detects the treatment interruption operation at the timing t5, the nebulizer control unit 71 stops the operation of the atomization unit 73 and generates the operation history information J2 regarding the operation of the atomization unit 73 started at the timing t4.
  • the operation history information J2 has three: timing t4 (operation start timing), time between timing t4 and timing t5 (operation time of atomizing unit 73), and chemical type atomized by atomizing unit 73. Consists of seeds.
  • the nebulizer control unit 71 adds the above-mentioned identification information (here, “M2”) to the operation history information J2. Then, the nebulizer control unit 71 transmits the operation history information J2 to which the identification information “M2” is added to the electronic device 3 at the timing t6 after the atomization unit 73 is stopped.
  • the nebulizer control unit 71 detects the treatment restart operation at the timing t7
  • the nebulizer control unit 71 activates the atomization unit 73.
  • the nebulizer control unit 71 detects the treatment end operation at the timing t8
  • the nebulizer control unit 71 stops the operation of the atomization unit 73 and generates the operation history information J3 regarding the operation of the atomization unit 73 started at the timing t7.
  • the operation history information J3 includes a timing t7 (operation start timing), a time between the timing t7 and the timing t8 (operation time of the atomizing unit 73), and a chemical liquid type atomized by the atomizing unit 73. Consists of seeds.
  • the nebulizer control unit 71 adds the same identification information "M2" as that added to the operation history information J2 to the operation history information J3. Then, the nebulizer control unit 71 transmits the operation history information J3 to which the identification information “M2” is added to the electronic device 3 at the timing t9 after the atomization unit 73 is stopped.
  • the electronic device 3 that has received the operation history information J2 and J3 from the nebulizer 1 transfers the operation history information J2 and J3 to the management server 6.
  • the operation history information J2 and J3 are recorded in the database 63.
  • the operation history information J3 relating to the operation of the atomization unit 73 started in response to the treatment resumption operation is obtained.
  • the common identification information "M2" is associated with the operation history information J2 regarding the operation of the atomizing unit 73 started in response to the treatment start operation before the treatment restart operation, and is transmitted to the electronic device 3. ..
  • the server control unit 62 of the management server 6 performs a process of combining the plurality of operation history information for a plurality of operation history information to which common identification information is added. conduct.
  • the server control unit 62 calculates, for example, the total value of the operation time included in the operation history information J2 and the operation time included in the operation history information J3, and uses this total value and the operation history information J2.
  • the operation history information J2A including the operation start timing of the atomizing unit 73 included and the information of the chemical solution type included in the operation history information J2 is generated.
  • the server control unit 62 records the operation history information J2A in association with the identification information “M2”. Then, the operation history information J2 and J3 are deleted from the database 63.
  • the management server 6 can manage the operation history information to which the common identification information is added as the operation history information at the time of one treatment. This makes it possible to prevent one treatment from being recognized as a plurality of treatments even when the operation history information recorded in the database 63 is referred to. As a result, the frequency of treatment using the nebulizer 1 can be accurately grasped, which can be useful for determining the treatment policy.
  • the total value of the operation time included in each of the plurality of operation history information to which the common identification information is associated makes it possible to roughly grasp the inhalation amount of the drug solution in one treatment. Therefore, the doctor can determine whether the appropriate treatment is performed by the user, which can be useful for determining the treatment policy.
  • the nebulizer 1 of the treatment management system 100 transmits the operation history information at the timing after the operation of the atomizing unit 73 is stopped (timing t3 in FIG. 6, timing t6 in FIG. 7). In this way, the operation history information is transmitted in a state where the ultrasonic transducer 41 of the atomizing unit 73 is not operating, so that the transmission is stable without being affected by the operating noise of the atomizing unit 73. Can be done. Therefore, the operation history information can be transmitted to the management server 6 without omission, and the treatment can be managed accurately.
  • the nebulizer control unit 71 of the nebulizer 1 When the nebulizer control unit 71 of the nebulizer 1 operates the atomization unit 73 in response to the treatment start operation, the nebulizer control unit 71 obtains operation history information regarding the operation of the atomization unit 73 started in response to the treatment start operation as an electronic device.
  • the atomization unit 73 is activated in response to the treatment restart operation by transmitting to 3
  • the operation history information regarding the operation of the atomization unit 73 started in response to the treatment restart operation is not transmitted to the electronic device 3. You may do so.
  • FIG. 8 is a timing chart for explaining a modified example of the operation of the nebulizer control unit 71 when the treatment is completed by the operation of the atomization unit 73 twice.
  • the difference between FIGS. 8 and 7 is that the information transmitted at the timing t6 is only the operation history information J2 (there is no identification information), and the transmission of the operation history information after the timing t8 is omitted. ..
  • the frequency of data transmission from the nebulizer 1 can be reduced, the continuous use time can be extended if the nebulizer is operated by a battery. Further, since it is not necessary to combine the operation history information in the management server 6, the processing load of the management server 6 can be reduced. In addition, the required capacity of the database 63 can be reduced.
  • the operation history information (J1, J2, J3) is the start timing of the operation period of the atomization unit 73 (the timing when the treatment start operation or the treatment restart operation is detected), and the operation time of the atomization unit 73. , And the type of chemical solution atomized by the atomizing unit 73.
  • the operation history information the following operation history information IF1 to IF3 may be adopted.
  • the operation history information IF1 is composed of the start timing of the operation period of the atomization unit 73, the end timing of the operation period of the atomization unit 73 (the timing when the treatment interruption operation or the treatment end operation is detected), and the drug solution type. Will be done.
  • the management server 6 can manage the timing at which the treatment is performed and the treatment time by obtaining the operation time of the atomizing unit 73 based on the start timing and the end timing.
  • the operation history information IF2 is composed of an end timing of the operation period of the atomization unit 73, an operation time of the atomization unit 73, and a chemical solution type.
  • the management server 2 manages the timing at which the treatment is performed and the treatment time by obtaining the start timing of the operation period of the atomizing unit 73 based on the end timing and the operation time. can.
  • the operation history information IF3 is composed of the operation time of the atomizing unit 73 and the type of chemical solution.
  • the management server 6 handles the timing at which the operation history information IF3 is received as the end timing of the operation period of the atomizing unit 73, so that the timing at which the treatment is performed and the treatment time Can be managed.
  • the operation history information (J1, J2, J3) described in the embodiment and the operation history information IF1 to IF3 of the modified example do not have to include the chemical solution type. Even in this way, if it is premised that the treatment is performed using a single type of drug solution, the timing and treatment time of the treatment can be controlled.
  • the operation history information IF4 composed of the start timing of the operation period of the atomization unit 73 or the end timing of the operation period of the atomization unit 73, the chemical solution type, and the chemical solution type may be adopted. Even in the operation history information IF4, if it is not necessary to manage the chemical solution type, the chemical solution type can be omitted.
  • a plurality of operation history information IF4s to which the same identification information is added are recorded in the database 63 as in the operation example of FIG. 7, only the oldest of the plurality of operation history information IF4s is left. And the others can be deleted.
  • the electronic device 3 may be omitted, and the nebulizer 1 and the management server 6 may communicate with each other via the network 4. Further, the management server 6 may be omitted, and the function of the management server 6 may be realized by the treatment management application installed in the electronic device 3. That is, the electronic device 3 may be configured to record and manage the operation history information.
  • Treatment management system 100 Treatment management system 1 Nebulizer 50 Operation member 51 Start / end button 53 Suspend / restart button 71 Nebulizer control unit 73 Atomization unit 3 Electronic device 4 Network 6 Management server

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Special Spraying Apparatus (AREA)

Abstract

La présente divulgation concerne un inhalateur pour traitement qui permet une gestion appropriée de l'historique de traitement.　Dans la présente invention, un nébuliseur (1) est pourvu : d'un élément d'actionnement (50) permettant d'effectuer une opération de démarrage de traitement afin d'émettre une instruction pour démarrer le traitement, une opération d'achèvement de traitement afin d'émettre une instruction pour achever le traitement, une opération d'interruption de traitement afin d'émettre une instruction pour interrompre le traitement, et une opération de redémarrage de traitement afin d'émettre une instruction pour redémarrer le traitement interrompu ; et d'une unité de commande de nébuliseur (71) qui gère un processus d'activation d'une unité d'atomisation (73) en réponse à l'opération de démarrage de traitement ou à l'opération de redémarrage de traitement, un processus d'arrêt de l'unité d'atomisation (73) en réponse à l'opération d'achèvement de traitement ou à l'opération d'interruption de traitement, et la transmission d'informations d'historique d'activation de l'unité d'atomisation (73) à un dispositif électronique (3). L'unité de commande de nébuliseur (71) modifie les détails de la gestion conformément aux détails de l'opération de l'élément d'actionnement (50).
PCT/JP2021/044545 2020-12-23 2021-12-03 Inhalateur pour traitement WO2022138081A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020213869A JP2022099843A (ja) 2020-12-23 2020-12-23 治療用吸入器
JP2020-213869 2020-12-23

Publications (1)

Publication Number Publication Date
WO2022138081A1 true WO2022138081A1 (fr) 2022-06-30

Family

ID=82159446

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/044545 WO2022138081A1 (fr) 2020-12-23 2021-12-03 Inhalateur pour traitement

Country Status (2)

Country Link
JP (1) JP2022099843A (fr)
WO (1) WO2022138081A1 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160346489A1 (en) * 2015-05-29 2016-12-01 Pari Pharma Gmbh Aerosol nebulizer control device
JP2017527868A (ja) * 2014-05-27 2017-09-21 レスメド・リミテッドＲｅｓＭｅｄ Ｌｉｍｉｔｅｄ 医療機器の遠隔データ管理
JP2019504696A (ja) * 2016-02-08 2019-02-21 パリ ファーマ ゲーエムベーハー 医療評価装置
US20190060590A1 (en) * 2016-04-14 2019-02-28 Mylan Inc. Systems, devices and methods for assessing inhalation therapy
JP2020500639A (ja) * 2016-12-09 2020-01-16 トゥルーデル メディカル インターナショナル スマートネブライザ

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017527868A (ja) * 2014-05-27 2017-09-21 レスメド・リミテッドＲｅｓＭｅｄ Ｌｉｍｉｔｅｄ 医療機器の遠隔データ管理
US20160346489A1 (en) * 2015-05-29 2016-12-01 Pari Pharma Gmbh Aerosol nebulizer control device
JP2019504696A (ja) * 2016-02-08 2019-02-21 パリ ファーマ ゲーエムベーハー 医療評価装置
US20190060590A1 (en) * 2016-04-14 2019-02-28 Mylan Inc. Systems, devices and methods for assessing inhalation therapy
JP2020500639A (ja) * 2016-12-09 2020-01-16 トゥルーデル メディカル インターナショナル スマートネブライザ

Also Published As

Publication number Publication date
JP2022099843A (ja) 2022-07-05

Similar Documents

Publication Publication Date Title
US20220040423A1 (en) Mobile inhaler and a container for using therewith
EP3414687B1 (fr) Dispositif d'évaluation médicale
KR20190055115A (ko) 공진형 음파 모터를 사용하여 청각 경보/표시를 발생시키기 위한 시스템, 디바이스, 및 방법
US20200329763A1 (en) Method and apparatus for an aerosol generation device
US11752278B2 (en) Mesh nebulizer
US10653178B1 (en) Method and apparatus for an aerosol generation device
CN105473175B (zh) 通过智能电话控制药物雾化器
WO2022138081A1 (fr) Inhalateur pour traitement
JP6686682B2 (ja) メッシュ式ネブライザおよび交換部材
JP2018038668A5 (fr)
WO2022138080A1 (fr) Dispositif de gestion, inhalateur thérapeutique, et programme de gestion
CN111201057B (zh) 网眼式雾化器和更换构件
WO2022138084A1 (fr) Inhalateur thérapeutique
WO2022138083A1 (fr) Inhalateur thérapeutique
JP7050187B6 (ja) 液滴出力を生成するシステムおよび洗浄をモニタリングする方法
WO2022270256A1 (fr) Nébuliseur
WO2022270257A1 (fr) Nébuliseur
JP2023004349A5 (fr)
JP2019051217A (ja) メッシュ式ネブライザ
WO2022249443A1 (fr) Procédé de traitement d'informations, terminal de traitement d'informations et système de traitement d'informations
KR20240027929A (ko) 분말 흡입 장치 및 그 제어 방법
TW202019510A (zh) 藥物投遞裝置

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21910232

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21910232

Country of ref document: EP

Kind code of ref document: A1